Laird Norton Wetherby Wealth Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$644K Buy
2,454
+10
+0.4% +$2.43K 0.03% 488
2025
Q2
$535K Buy
+2,444
New +$522K 0.02% 534
2024
Q4
$1.03M Buy
3,135
+21
+0.7% +$6.61K 0.05% 333
2024
Q3
$935K Sell
3,114
-126
-4% -$38.6K 0.04% 378
2024
Q2
$1.07M Sell
3,240
-58
-2% -$20.5K 0.05% 335
2024
Q1
$1.31M Sell
3,298
-53
-2% -$19.6K 0.06% 299
2023
Q4
$1.18M Buy
3,351
+9
+0.3% +$3.19K 0.06% 317
2023
Q3
$1.25M Buy
3,342
+6
+0.2% +$2.32K 0.07% 286
2023
Q2
$1.28M Sell
3,336
-15
-0.4% -$5.36K 0.07% 287
2023
Q1
$1.16M Buy
3,351
+183
+6% +$53.5K 0.07% 304
2022
Q4
$746K Buy
3,168
+381
+14% +$90.3K 0.05% 393
2022
Q3
$686K Sell
2,787
-341
-11% -$104K 0.05% 384
2022
Q2
$946K Buy
3,128
+2,306
+281% +$750K 0.06% 309
2022
Q1
$338K Buy
822
+44
+6% +$17.2K 0.02% 674
2021
Q4
$365K Buy
778
+109
+16% +$46.9K 0.02% 645
2021
Q3
$284K Buy
669
+26
+4% +$11K 0.02% 728
2021
Q2
$231K Buy
+643
New +$212K 0.01% 811
2020
Q1
Sell
-2,272
Closed -$342K 754
2019
Q4
$342K Buy
2,272
+79
+4% +$11.5K 0.03% 500
2019
Q3
$311K Sell
2,193
-40
-2% -$5.51K 0.03% 536
2019
Q2
$279K Hold
2,233
0.03% 564
2019
Q1
$246K Sell
2,233
-15
-0.7% -$1.56K 0.03% 566
2018
Q4
$220K Hold
2,248
0.03% 560
2018
Q3
$278K Hold
2,248
0.03% 516
2018
Q2
$223K Buy
+2,248
New +$207K 0.03% 571
2018
Q1
Sell
-2,082
Closed -$205K 695
2017
Q4
$205K Hold
2,082
0.03% 596
2017
Q3
$200K Buy
+2,082
New +$188K 0.03% 576

Other funds holding WST